0.1750
-0.1750
(-50.00%)
As of 8:05:03 AM GMT+1. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
11,816.3530
6,472.6620
11,802.7960
1,620.0650
Total Liabilities Net Minority Interest
6,339.5340
1,753.1090
2,078.1840
766.5250
Total Equity Gross Minority Interest
5,476.8190
4,719.5530
9,724.6120
853.5400
Total Capitalization
5,476.8190
4,719.5530
9,724.6120
853.5400
Common Stock Equity
5,476.8190
4,719.5530
9,724.6120
853.5400
Net Tangible Assets
5,476.8190
4,719.5530
9,724.6120
853.5400
Working Capital
2,992.0710
3,561.5180
9,281.9550
810.6710
Invested Capital
5,476.8190
4,719.5530
9,724.6120
853.5400
Tangible Book Value
5,476.8190
4,719.5530
9,724.6120
853.5400
Share Issued
301,405.9500
288,133.9570
287,150.9710
245,626.9260
Ordinary Shares Number
301,405.9500
288,133.9570
287,150.9710
245,626.9260
12/31/2020 - 2/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1GDA.F Zevra Therapeutics, Inc.
7.65
+2.68%
CVAC.VI CureVac N.V.
3.7300
-0.75%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4540
-1.73%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
PI3.DU Gubra AS
87.80
-0.90%
471A.F aTyr Pharma, Inc.
3.5800
+3.47%
1AEA.F argenx SE
635.00
+2.42%